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According to clinical studies, around one third of patients with atrial fibrillation (AF) will
suffer a stroke during their lifetime. Between 70 and 90% of these strokes are caused
by thrombus formed in the left atrial appendage. In patients with contraindications
to oral anticoagulants, a left atrial appendage occluder (LAAO) is often implanted to
prevent blood flow entering in the LAA. A limited range of LAAO devices is available,
with different designs and sizes. Together with the heterogeneity of LAA morphology,
these factors make LAAO success dependent on clinician’s experience. A sub-optimal
LAAO implantation can generate thrombi outside the device, eventually leading to
stroke if not treated. The aim of this study was to develop clinician-friendly tools
based on biophysical models to optimize LAAO device therapies. A web-based 3D
interactive virtual implantation platform, so-called VIDAA, was created to select the
most appropriate LAAO configurations (type of device, size, landing zone) for a given
patient-specific LAA morphology. An initial LAAO configuration is proposed in VIDAA,
automatically computed from LAA shape features (centreline, diameters). The most
promising LAAO settings and LAA geometries were exported from VIDAA to build
volumetric meshes and run Computational Fluid Dynamics (CFD) simulations to assess
blood flow patterns after implantation. Risk of thrombus formation was estimated from
the simulated hemodynamics with an index combining information from blood flow
velocity and complexity. The combination of the VIDAA platform with in silico indices
allowed to identify the LAAO configurations associated to a lower risk of thrombus
formation; device positioning was key to the creation of regions with turbulent flows after
implantation. Our results demonstrate the potential for optimizing LAAO therapy settings
during pre-implant planning based on modeling tools and contribute to reduce the risk
of thrombus formation after treatment.
Keywords: left atrial appendage occlusion, Computational Fluid Dynamics, in silico optimization of therapies,
web-based implantation platform, atrial fibrillation
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1. INTRODUCTION
Atrial Fibrillation (AF) is the most common cardiac arrhythmia
diagnosed in clinical practice, affecting around 0.4–1% of the
general population (Singh and Holmes, 2010). The atria beat
irregularly during AF, which leads to ineffective blood flow
pumping to the ventricles. The consequences of AF have been
clearly established in multiple studies, being one of them the
increased risk of stroke; one out of three ischemic strokes is
related to AF (Boston Scientific, 2018). Between 70 and 90%
of AF-related strokes originate from thrombus formed in a
cavity of the left atrium, the left atrial appendage (LAA) (Wang
et al., 2010; Lee et al., 2015). The LAA is a contractile reservoir
and a decompression chamber, depending on the cardiac cycle
phase (Fatkin et al., 1994; Al-Saady et al., 1999). It acts as
a suction during ventricular systole and during diastole as a
conduit. In addition, the LAA is characterized by its high
morphological variability, in parameters such as size, height,
smoothness or number of lobes. The different LAAmorphologies
are often classified into four categories: chicken wing, cauliflower,
windsock and cactus (Di Biase et al., 2012). Left atrial motion
irregularity due to AF causes a deceleration of blood flow
and stasis, increasing the risk of thrombus formation in the
LAA (Markl et al., 2016). The thrombus formed can then
travel through the circulatory system to the brain, causing a
cardioembolic stroke.
Oral anticoagulation (OAC) therapy is usually prescribed on
those AF patients older than 65 years old (Morillo et al., 2017)
to reduce the risk of thrombus formation. When OAC therapy
is not appropriate, due to high risk of bleeding or because
of patient’s limitations, a physical LAA closure is performed
with the implantation of a left atrial appendage occlusion
(LAAO) device or surgery-based clipping (Le et al., 2014).
LAAO devices are implanted percutaneously by a femoral vein
approach under fluoroscopic and echocardiographic guidance.
The most used LAAO devices available in the market (see
Figure 1) are the Watchman (Boston Scientific, 2018) and
the Amplatzer Amulet (Abbott, 2018), even if new promising
devices such as the Lambre (Park et al., 2018) and the
Wavecrest (Saw and Lempereur, 2014) are being proposed
every year. In a LAAO procedure, the large intra-subject
anatomical variation of the LAA influences the individual
implantation. Therefore, biomedical images are acquired to
have good anatomical knowledge of the cavity, before and
during the intervention. In most clinical centers X-ray and
transesophageal echocardiography (TEE) images are used to
characterize the LAA morphology during the intervention
to support decisions on device implantation. Other imaging
modalities such as Computed Tomography (CT) (Chow et al.,
2017) and 3D Rotational Angiography (3DRA) (De Potter et al.,
2018) are also being explored in advanced hospitals to have
higher-resolution structural information before and during the
intervention, respectively. The ostium (interface betwen LA and
LAA) dimensions and height/depth of the LAA cavity (Morillo
et al., 2017) are critical LAA shape parameters to individualize the
size of the implanted device and the landing zone (location where
the device will be released). Appropriate sizing of the device,
achieving a complete clinical closure, allows the procedure
to be finished earlier since a second device is not required.
A minimal leakage of jet blood flow entering into the LAA
after device implantation is the standard criteria to define a
successful closure (López-Mínguez et al., 2014). Unfortunately,
LAA shape parameters are usually estimated from medical
images with manual tools, being difficult to standardize criteria
to objectively define them. Moreover, values of these parameters
coming from different imaging modalities differ substantially
due to their respective spatial resolution and limitations
(López-Mínguez et al., 2014).
Beyond their morphology, studying LA and LAA
hemodynamics is also important before and after LAAO
treatment. The Virchow’s triad defines blood hypercoagulability,
hemodynamics changes and endothelial wall injury dysfunction
as the three main players in thrombus formation (Chung and
Lip, 2003). Left atrial appendage blood flow velocities below
some threshold (<0.2 m/s) have been associated to the presence
of thrombus in the LAA (Beigel et al., 2014). Unfortunately, most
clinical studies (Beigel et al., 2014) involving the LAA, usually
based on echocardiographic images, only report a single blood
flow velocity value in one point in space (LAA ostium) and in
time (end diastole), which constitutes an over-simplification
of the complex hemodynamics in the LA and LAA. Detailed
hemodynamics characterization is becoming possible these days
with advanced 4D-flow magnetic resonance imaging technique,
but there are few studies in the LA (Casas et al., 2017; Cibis
et al., 2017a,b) and only one in the LAA (Markl et al., 2016).
Some researchers (Zhang and Gay, 2008; Koizumi et al., 2015;
Vedula et al., 2015; Otani et al., 2016; Olivares et al., 2017; Bosi
et al., 2018; García-Isla et al., 2018) have developed biophysical
modeling pipelines for a more detailed in silico analysis of LAA
blood flow patterns with Computational Fluid Dynamics (CFD)
simulations. However, none of these works studied the effect
of implanting a LAAO device with different settings on atrial
hemodynamics. In addition, as in the majority of biomedical
applications, these biophysical models remain an engineering
tool far from being used to support clinicians on their decisions.
Even if LAAO devices are generally becoming an accepted
option when OAC therapy fails, it still exists controversy
concerning the safety and the real clinical benefit of LAAO-based
therapy. Although it seems to be effective, short- and long-term
consequences are not fully known (Mandrola et al., 2018). As an
example, a recent clinical trial (Fauchier et al., 2018) reported
a high probability of getting a device-related thrombus (around
7%). Moreover, LAAO is recognized as a technically demanding
procedure, requiring rigorous training and skills in order to
reduce complications (Tzikas et al., 2016). However, there is a lack
of advanced computational tools to provide a complete, objective
and patient-specific characterization of LAA morphology and
function to assist clinicians on the challenging LAAO device
selection and planning steps. The aim of this work was to
develop a clinician-friendly visualization tool to be combined
with biophysical modeling for LAAO therapy optimization. A
web-based 3D interactive virtual implantation platform, so-
called VIDAA (Virtual Implantation and Device selection in
left Atrial Appendages), was designed and implemented to
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FIGURE 1 | Pictures (top) and Computational-Aided Design models (bottom)
of left atrial appendage occlusion devices. (A) Amplatzer Amulet (Abbott,
2018); (B) Watchman (Boston Scientific, 2018).
jointly visualize the LA anatomy of an individual patient and
different possible LAAO configurations. The VIDAA platform
initially proposes LAAO setting parameters estimated after a
morphological analysis of the LAA under study. The clinician
later can interactively vary device parameters in VIDAA and
export outside the platform the most promising configurations.
Computational Fluid Dynamics (CFD) simulations were then
run with a commercial solver for several LAAO configurations
extracted from VIDAA to estimate their corresponding risk
of thrombus formation after implantation. As a first proof of
concept, the VIDAA platform was tested on retrospective data
of four non-valvular AF patients that underwent a LAA closure.
2. MATERIALS AND METHODS
The computational workflow designed in this work (see Figure 2)
is a planning tool that, together with computational modeling,
provides enhanced individualized information to the clinician
before the intervention. In all analyzed cases, surface meshes
of the LA were reconstructed from binary masks obtained
segmenting high-resolution 3D medical images (CT and 3DRA).
In the next step, morphological indices characterizing patient-
specific LAA shapes were automatically calculated. Based on
these LAA shape-based indices, a range of optimal LAAO
device parameters (size, position) were estimated. The optimal
configuration for the two most popular devices (e.g., Watchman
and Amplatzer Amulet) could then interactively be explored
together with a 3D rendering of the LA in the web-based
VIDAA platform. The clinician could manually modify several
LAAO parameters to better understand the case under study and
plan the intervention. Once a given LAAO configuration was
considered appropriate by the clinician, the VIDAA platform
exported all data (e.g., meshes and their spatial relationship)
that will define the geometrical domain where CFD simulations
were run outside VIDAAwith a commercial software. Simulation
results were post-processed to derive in silico hemodynamics
indices estimating the risk of thrombus formation for a given
TABLE 1 | Patient and device information.
Patient Medical image CHAD2VASC Device type Device size
(mm)
1 3DRA 3 Watchman 27
2 3DRA 3 Watchman 30
3 3DRA 6 Watchman 27
4 CT 5 Amplatzer Amulet 22
3DRA, 3D Rotational Angiography; CT, Computed Tomography; CHAD2VASC, clinical
index characterizing the risk of thrombus formation.
LAA and device setting. The VIDAA platform in combination
with CFD simulations then allowed the clinician to decide, prior
to the intervention, which device configuration was safer, in
terms of thrombus formation.
2.1. Patient-Specific Imaging Data and
Processing
Three-dimensional medical images were available for the four
AF patients analyzed in this study: 3DRA images of three
patients from OLV Hospital (Aalst, Belgium); and a CT image
of one patient from Hospital Clínic de Barcelona (Spain).
The OLV Hospital and Hospital Clínic de Barcelona ethical
committees approved this study and written informed consent
was obtained from every participant before the procedure.
Watchman devices were implanted to patients at OLV Hospital
while an Amplatzer Amulet was the choice at Hospital Clínic de
Barcelona (see Table 1). All patients had persistent non-valvular
atrial fibrillation with high risk of thrombus formation (e.g.,
CHAD2VASC > 2).
An InnovaTM monoplane fluoroscopy system (GEHealthcare,
LLC, Waukesha,WI) was used at OLV Hospital to acquire the
3DRA images, with 0.23 or 0.45 mm pixel size for 512 or 256
isotropic voxels, respectively. Before and during the injection,
the right ventricle was burst paced at a cycle length of 200
ms during end-expiratory apnea to interrupt the blood flow
through the LA. All datasets were segmented by an experienced
operator on the Advantage Workstation (GE Healthcare) using
the Innova 3D software to reconstruct the LA, which is based
on threshold and region-growing semi-automatic segmentation
techniques. The CT image at Hospital Clínic de Barcelona was
acquired using a SiemensTM machine, synchronized with ECG
and supplying 80 ml of contrast, having a volumetric pixel size
of 0.33 × 0.33 × 0.40 mm for an in-plane matrix of 512 pixels
and 430 slices. The ITK-Snap1 software (Yushkevich et al., 2006)
was used to semi-automatically segment the LA in the CT image
(also with region growing and threshold-based techniques, plus
manual corrections). The LA binary masks from segmenting
3DRA and CT images were the basis to construct surface meshes
with the Marching Cubes method for subsequent morphological
analysis and simulations. A 2D plane was manually selected by
the operator to define the ostium and the LAA in the LA 3D
surface mesh.
1www.itksnap.org
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FIGURE 2 | Computational workflow to recommend optimal left atrial appendage occlusion (LAAO) settings for a selected patient. The first stage produces LAA
morphological measures from LA segmentations obtained on three-dimensional medical images. Computational 3D renderings of LA/LAA geometries are then jointly
visualized with morphological measures and Computer-Aided Design models of LAAO devices in the VIDAA platform. The VIDAA platform allows an interactive and
individualized virtual implantation of LAAO devices, generating multiple configurations that can be exported for further processing. Computational-Fluid Dynamics
(CFD) simulations run on the exported LAAO configurations provide hemodynamics descriptors to estimate the risk of thrombus formation for each case, which are
finally reported to clinicians to support their decisions.
2.1.1. Left Atrial Appendage Morphological
Parameters and Optimal Device Configuration
Two types of morphological parameters were automatically
estimated from LAA surface meshes: ostium- and centreline-
based parameters. The ostium area, perimeter and principal axes
were computed directly from surface mesh elements labeled
as ostium after the segmentation. The LAA centreline (see
and example in Figure 3) was obtained following a marching
algorithm (Genua et al., 2019), where its starting point (the
furthest point of the LAA) and the centreline direction to the
ostium were computed applying a heat transfer propagation
simulation to the LAA volumetric mesh. Once the centreline
was estimated, several transversal 2D planes, perpendicular to its
main direction, were selected along its length to compute their
maximal (D1) and minimal (D2) diameters.
The centreline-based parameters were used to automatically
estimate the optimal LAAO configuration for the analyzed
anatomy, as illustrated in Figure 3. Following criteria defined by
our experienced clinicians, device (center) positioning was set
at a geodesic distance along the centreline of 10 and 13 mm
from the ostium for the Amplatzer Amulet and the Watchman,
respectively. The diameters (D1, D2) of the transversal 2D plane
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centered at the optimal device positioning were then computed.
The initial orientation of the LAAO device was set perpendicular
to the centreline. Based on empirical algorithms from clinicians
and official device instructions, the most appropriate LAAO
device sizes (three for the Amplatzer Amulet and two for
the Watchman) were initially selected. For instance, optimal
Amplatzer Amulet device sizes were established following the
current clinical protocol at Hospital Clínic de Barcelona: 2–5
or 3–6 mm are usually added to the average mean diameter
(between D1 and D2) if imaging data comes from CT or TEE,
respectively. If the obtained size is smaller than D1, additional
2–5 mm are added. Finally, only devices ensuring at least a
10% of compression of original size after implantation were
selected. Fulfilling the compression-based criteria increments the
likelihood of getting the LAAO device attached to the wall for
a successful closure, without creating too high stresses on the
LAA. The optimal sizes for the Watchman device (see Table A.1
in Appendix 1) were selected based on D1, following official
device instructions.
2.2. VIDAA: Virtual Implantation and Device
Selection in Left Atrial Appendages
VIDAA is a web-based 3D interactive virtual implantation
platform that allows clinicians to select the most appropriate
LAAO configurations for a given patient. The main features
of the VIDAA platform include: the joint 3D visualization of
the LA/LAA surface meshes and the device models; different
modes of mesh visualization and editing tools such as wireframe
views or clipping, among others; transform controllers for user
manipulation of the device such as translation, rotation and
scaling; visualization of LAA morphological parameters such as
the centreline, 2D transveral planes of the centreline and its
diameters (D1, D2); visualization of the optimal LAA settings
according to VIDAA such as device size and landing zone;
manual modification of all LAAO settings; and export of a LAAO
configuration for subsequent in silico hemodynamics study.
Figure 2 illustrates the different steps in the VIDAA workflow. A
demonstration video of a proof-of-concept prototype of VIDAA
is also available as Supplementary Material (Appendix 2).
Being a web-based platform, VIDAA is not linked to
any software installation, operative system or browser, which
facilitates its usage in a clinical environment. VIDAA was built
using HTML5 programming language (JavaScript, scss), using
different JavaScript libraries such as THREE.js and React.js. The
first library, THREE.js, was used to visualize and interact with 3D
objects (e.g., LA mesh) while React.js was used to separate into
components the different modalities of the platform.
2.3. Hemodynamics Simulations
2.3.1. Mesh Processing Pipeline
To ensure convergence of hemodynamics simulations, LA
meshes from medical image segmentations required several pre-
processing phases (see Figure 4). First, a Taubin smoothing
filter (with scale factors λ = 0.6, µ = –0.53 and 10 iterations)
was applied. Subsequently, cylinders representing the pulmonary
veins (PV) and the mitral valve (MV) were manually inserted
FIGURE 3 | Computational pipeline to obtain optimal left atrial appendage
occlusion (LAAO) device configuration. Device positioning (e.g., landing zone)
is initially estimated at a certain geodesic distance from the ostium following
the LAA centreline (10 and 13 mm for the Amplatzer Amulet and Watchman,
respectively). Device orientation is set perpendicular to the LAA centreline.
LAAO size is based on the maximum diameters (D1 & D2) of a transversal 2D
plane perpendicular to the centreline placed in the optimal positioning. The
proposed LAAO devices are initially shown in the VIDAA platform with these
settings (VIDAA-init), where the clinician can interactively manipulate all their
parameters for a better fitting to the studied LAA morphology (VIDAA-end).
to the LA mesh using the Autodesk Meshmixer software2
so that simulated flow was developed normal to the surface
of the vessels. Volumetric meshes were built with a 3D
Delaunay refinement algorithm available in the Gmsh software
(default parameters) (Geuzaine and Remacle, 2009)3 for the
subsequent CFD simulations, resulting in the following number
of tetrahedral elements for the four LA under study: Patient
1 = 597,550; Patient 2 = 961,015; Patient 3 = 330,091; Patient
4 = 200,951. The whole meshing pipeline was performed
with the following Open-Source softwares: Gmsh, Autodesk
MeshMixer, MeshLab4 and Visual Computing Lab5. The reader
is referred to García-Isla et al. (2018) for more details of the
meshing pipeline.
The studied LAAO devices (see Figure 1) were built
using a Computational-Aided Design (CAD) software6 and
following the on-line product manual and instructions from the
companies (Abbott, 2018; Boston Scientific, 2018). Subsequently,
several LAAO device configurations, including different size and





6Geometry-Design Modeler (Ansys 18.2)
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FIGURE 4 | Mesh processing pipeline for hemodynamics simulations: (A) Computed Tomography (CT) image; (B) Surface mesh after CT segmentation; (C) Removal
of structures surrounding the left atrium (LA); (D) Insertion of cylinders for the pulmonary veins (PV); (E) Volumetric LA mesh with two right pulmonary veins (RPVs), two
left pulmonary veins (LPVs), a mitral valve (MV) and the left atrial appendage (LAA).
Volumetric meshes for all configurations under study were
obtained defining two surfaces in Gmsh: one for the LA and
another for the implanted device.
2.3.2. Computational Fluid Dynamics
The CFD analysis was performed using ANSYS Fluent 18.2, in
which blood was modeled as an incompressible Newtonian fluid
(density of ρ= 1,060 kg/m3; dynamic viscosity ofµ = 0.0035 Pa·s).
Blood was simulated using the incompressible Navier-Stokes
and continuity equations. Model dynamics was introduced with
a sinusoidal function representing a heart cycle of a healthy
patient (Fernandez-Perez et al., 2012; García-Isla et al., 2018).
Boundary conditions at systole (first 0.40 s) were modeled with
the PVs as velocity-inlets and the MV as a wall, to represent that
the valve is closed during this cardiac phase (Fernandez-Perez
et al., 2012). The opening of the MV in diastole (duration of 0.65
s) was modeled applying an outlet pressure of 8 mmHg (Nagueh
et al., 2008) to the MV. All LA walls were modeled as rigid walls
with no slip, representing the worst scenario in (persistent) AF,
where the atrium barely contracts anymore. The LAAO device
was also modeled as a wall to represent that no blood could go
through it.
2.3.3. In silico Indices for Risk of Thrombus Formation
As in García-Isla et al. (2018), we estimated several in silico
indices to characterize blood flow patterns derived from
CFD simulations and identify pro-thrombotic regions in the
LAA, usually where blood flow is complex and velocities are
low (Achille et al., 2014). For the sake of simplicity, only the
Endothelial Cell Activation Potential (ECAP) index is reported
here since it combines the Time-Averaged Wall Shear Stress
(TAWSS) with the Oscillatory Shear Index (OSI): low velocity
(small TAWSS values) and high complex (large OSI values) blood
flows will produce high ECAP values, thus indicating a region
with a high risk of thrombus formation.
The equations to derive these indices are included in
Appendix 3. For a qualitative analysis, the in silico indices were
visualized (using ParaView 5.2.0) as colored maps superimposed
on the 3D LA geometry, providing an intuitive way to detect
regions with irregular blood flow. Furthermore, the distribution
in the LAA of the ECAP index for different simulation scenarios
was analyzed with histograms showing the percentage of nodes
in different ECAP intervals.
2.3.4. Simulation Scenarios
In silico blood flow patterns were studied in different simulation
scenarios to study the influence of the implanted device
configuration. Four simulation scenarios were studied for each
patient, resulting in a total number of 16 simulations:
• Without LAAO device (No LAAO).
• LAAO device with size and positioning derived from
morphological analysis and criteria defined by experienced
clinicians (see section 2.1.1); this is the default configuration
shown in the VIDAA platform (VIDAA-init).
• LAAO device with VIDAA-init settings but with a 20%
smaller size.
• LAAO device VIDAA-init settings but with a sub-optimal
position and orientation (Misplaced).
• LAAO device after manipulation in VIDAA aiming
at uniformly covering the union between the LA and
LAA (VIDAA-end).
3. RESULTS
3.1. Blood Flow Velocity Patterns
Streamlines and velocity vector fields characterizing blood flow
patterns in the LA/LAA for different simulation scenarios were
analyzed. Figure 5 shows simulation results for the four patients
under study and the LAAO configurations described above, in
diastole (t= 0.55 s, ventricular filling), when blood flow velocities
in the LAA are higher. Videos of the hemodynamics simulations
(blood flow velocity streamlines for the whole cardiac cycle) for
all patients without a device and with the VIDAA-end settings are
included as Supplementary Material (see Appendix 2).
At baseline (without an implanted LAAO device, No LAAO
configuration, first row in Figure 5), blood flow is entering the
LAA in all patients with relatively low velocities, in some cases
with complex patterns (e.g., Patient 3) in secondary lobes. The
device configuration proposed by the VIDAA platform (both
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FIGURE 5 | Blood flow streamlines in the left atrial appendage (LAA) from hemodynamics simulations of the four patients under study. Snapshots capture the flow
behavior in diastole, when higher velocities are present (t = 0.55 s). No LAAO: without device; VIDAA-init: device settings from morphological analysis and clinical
recommendations; VIDAA-end: device settings after interactive manipulation in VIDAA; 20% smaller: device with a 20% smaller size than VIDAA-init; Misplaced: device
with sub-optimal position and orientation.
VIDAA-init and VIDAA-end) achieved a perfect occlusion in
Patient 1 (second and third row, first column, in Figure 5).
On the other hand, blood flow was penetrating the LAA in
the same case when decreasing the LAAO device size (20%
Smaller scenario), showing a potential stagnation process, with
low velocities, in the lateral part of the occluder (blue arrows
next to the device; fourth row, first column, in Figure 5). All
configurations have the device positioning deeper in the LAA
than the VIDAA-end, creating a non-closed cavity between the
ostium and the device where new complex blood flow loops
appeared. Patient 2 presented a similar behavior to Patient 1
but with a more visible negative effect of reducing the size of
the device, allowing more flow through the LAA (fourth row,
second column, in Figure 5). On the other hand, Patient 3
(third column in Figure 5) showed a correct flow blockage in
all device configurations. Finally, Patient 4 showed fast velocities
and laminar flow in the LA cavity outside the implanted device
for the VIDAA-end configuration (red streamlines in third row,
fourth column in Figure 5), which was not achieved with the
remaining settings.
Figure 6 depicts blood flow velocity curves over the whole
cardiac cycle in a point outside the device (following the LAA
centerline direction toward the main LA cavity) for all simulation
scenarios in the four patients analyzed in this work. We can
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FIGURE 6 | Blood flow velocity curves over the whole cardiac cycle in a point outside the device in the left atrial cavity for all simulation scenarios in the four patients.
VIDAA-init: device settings from morphological analysis and clinical recommendations; VIDAA-end: device settings after interactive manipulation in VIDAA; 20%
smaller: device with a 20% smaller size than VIDAA-init; Misplaced: device with sub-optimal position and orientation.
appreciate that the VIDAA-end configuration (red curve in
Figure 6) leads to velocity profiles with higher magnitudes in
diastole for some cases (e.g., see Patient 4), suggesting faster flow
circulation and thus less risk of thrombus formation due to device
implantation. On the other hand, results are inconclusive for
other patients (e.g., see Patient 3), exemplifying the difficulty of
characterizing the 4D nature of blood flow patterns by observing
1D velocity profiles in an individual spatial point.
3.2. In silico Indices for Risk of Thrombus
Formation
Figure 7 shows the ECAP distribution mapped as a colormap
onto the LA/LAA geometries for all simulation scenarios in the
patients under study. For LAAO scenarios (i.e., all except the
No LAAO), the ECAP map is only displayed between the LAA
ostium and the device to study the risk of thrombus formation
outside the device. It can easily be observed at baseline (No
LAAO configuration; first row in Figure 7) that higher values
of ECAP (i.e., complex flows and low velocities; red-green areas
in Figure 7), thus with a higher risk of thrombus formation, are
located in several areas of the LAA depending on morphology
complexity. For instance, Patient 4 is the case showing smaller
ECAP values due to its smooth morphology and orientation
with respect to the main LA cavity, leading to larger blood
flow velocity magnitudes in most regions (except in its tip).
More importantly, high ECAP areas appear more prominently
in device configurations with incorrect LAAO settings (e.g.,
20% smaller), whereas the VIDAA-end configuration seems to
minimize the presence of these areas.
Figure 8 plots the histograms of ECAP intervals as
percentages with respect to surface area for each patient
and different LAAO scenarios. The ECAP maps were analyzed
within the region between the device and the LAA ostium. For
the four analyzed LAA geometries, the VIDAA-end settings
resulted in the lower percentage of surface areas with higher
ECAP values (>3). We can also observe that the VIDAA-init
settings were not always adequate, sometimes even performing
worse than the Misplaced and 20% smaller scenarios, illustrating
the benefit of interactively manipulating the device settings in
the VIDAA platform.
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FIGURE 7 | Endothelial Cell Activation Potential (ECAP) distribution (Pa−1) visualized as colored maps superimposed to the LA wall for the four patients under study.
No LAAO: without device; VIDAA-init: device settings from morphological analysis and clinical recommendations; VIDAA-end: device settings after interactive
manipulation in VIDAA; 20% smaller: device with a 20% smaller size than VIDAA-init; Misplaced: device with sub-optimal position and orientation.
4. DISCUSSION
In this study, different configurations of LAA occlusion devices
were evaluated in four patient-specific left atria using advanced
computational tools. A web-based platform, so-called VIDAA,
was developed in which LAAO devices could be virtually
implanted, interactively selecting the desired configuration for a
given individual. Once a device configuration was chosen, it was
exported out of the platform to built a computational domain
where hemodynamics CFD-based simulations were run. The
resulting blood flow simulations were post-processed to generate
quantitative in silico indices (e.g., ECAP) to locally assess the risk
of thrombus formation after device implantation, which is not
currently possible with existing imaging modalities. Providing
such information for different LAAO settings to the clinician
would be quite beneficial for a better and faster planning of
the intervention.
The implantation of LAAO devices is usually quite successful
(around 95%, defined as small flow jets into the LAA
after implantation), with peri-procedural complicate rates of
approximately 5% (Grosset-Janin et al., 2015). Nevertheless,
residual bleedings are not uncommon and the reduction of
thrombus formation risk, even if superior to OAC-based
therapy, could be improved (60–75% Grosset-Janin et al.,
2015). Moreover, it is not well-known when patients can stop
anti-coagulants after LAAO implantation, which can lead to
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FIGURE 8 | Histograms of Endothelial Cell Activation Potential (ECAP) distribution (Pa−1) as a percentage of surface area for each patient and different device
scenarios. VIDAA-init: device settings from morphological analysis and clinical recommendations; VIDAA-end: device settings after interactive manipulation in VIDAA;
20% smaller: device with a 20% smaller size than VIDAA-init; Misplaced: device with sub-optimal position and orientation.
device-related thrombus formation (7% of cases in a recent
study Fauchier et al., 2018). The development of advanced
computational tools including 3D medical imaging, clinician-
friendly interfaces and biophysical modeling to fully characterize
the LAA 3D morphology, 4D blood flow patterns and virtually
predict the individual risk of thrombus formation for different
device settings, would contribute to the acceptance of LAAO
therapies, properly assessing their cost-effectiveness and clinical
benefit as well identifying their limitations, which is still under
debate (Hu and Yogeswaran, 2015; Mandrola et al., 2018).
The obtained results confirm the relevance of an appropriate
LAAO device configuration, personalized to each patient, to
ensure a complete occlusion of the LAA cavity and minimize
the creation of areas around the implanted device prone to
thrombus formation (e.g., low velocities and complex flow).
Consistently, LAAO settings obtained after device manipulation
in the VIDAA platform (VIDAA-end) were themost appropriate,
ensuring a complete blockage of the LAA cavity in all cases.
On the contrary, other LAAO configurations, including the
VIDAA initial configuration based on LAA morphological
analysis and clinical recommendations (VIDAA-init), repeatedly
created complex flow loops with low velocities around the device,
incrementing the risk of thrombus formation post-intervention.
However, the VIDAA-end positioning of the device may not be
adequate if it leads to a blockage of the circumflex artery, which
is located just outside the LAA ostium. Unfortunately, we did not
have information about the circumflex artery exact location in
the studied cases. In the future, this information will be obtained
from CT images and added as an additional constraint in the
VIDAA platform.
Device sizing and positioning are then crucial, assuming
a good attachment to the LAA wall. Nowadays, the process
for selecting the LAAO size and defining the landing zone
where the device will be released is too subjective and prone
to errors due to the lack of quantitative techniques and high-
resolution 3D images. We have observed in our study that
small changes in the selection of transversal 2D planes along
the LAA centerline produced maximum diameters in the range
of 22–31 mm in the same geometry. Similar variability can
be found when using 2D-based or different medical imaging
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modalities, as it was demonstrated in López-Mínguez et al.
(2014), where LAAO dimensions were consistent from X-
ray, echocardiography and CT images in only 23% of the
cases. Therefore, a full 3D characterization of the LA/LAA
geometry (i.e., dimensions, relative orientation) is required
for an optimal device sizing/positioning and avoid generating
areas between the implanted device and the atrial wall prone
to thrombus formation. A reduced learning curve of the
LAAO device implantation process and more comprehensive
intervention planning has already been demonstrated by using
CT images (Wang et al., 2016; Chow et al., 2017). Recently (De
Potter et al., 2018), 3DRXA has also been proven an interesting
alternative to echocardiographic images during the intervention.
The VIDAA platform has then been developed to allow
the interactive 3D visualization of LA/LAA geometries and
CAD models of the devices. The integration of VIDAA with
hemodynamics simulations has been very helpful to identify
areas with high risk of thrombus formation under certain
LAAO configurations. The ECAP parameter, initially proposed
by Achille et al. (2014) in an aortic aneurysm application,
provided consistent results, with higher values in the LAA
and showing its potential to estimate thrombogenesis. Overall,
the VIDAA platform and biophysical models should provide a
more complete way to analyze the relation between LAA shape,
hemodynamics, device settings and thrombus formation to the
clinicians prior to the intervention.
The presented methodology has several limitations that
could be improved in the future. For instance, the 3D
model construction, including image processing steps (e.g.,
segmentation, definition of ostium plane) and the meshing
pipeline, is semi-automatic, which could lead to intra-operator
inconsistencies. The obtained image processing results and
corresponding 3D models were qualitatively evaluated by several
observers for each case. However, even if developing a fully
automatic image processing pipeline was out of the scope of this
paper, left atrial segmentation techniques based on deep-learning
algorithms are already becoming available (see recent Atrial
Challenge at STACOM18 workshop7). Sensitivity analysis and
convergence studies will also identify the most critical meshing
pipeline parameters, such as the required mesh resolution, to
obtain robust wall shear stress maps, which is critical to estimate
reliable ECAP maps.
Moreover, several boundary conditions and modeling choices
could be upgraded to achieve more realistic simulations. The
assumption of rigid LA walls for a persistent AF patient is
valid from a clinical point of view. Nevertheless, the LAA
is quite a flexible structure and the mitral ring displacement
is non-negligible to properly simulate LA reservoir, conduit
and booster pump phases. Motion-based constraints could
be imposed from patient-specific information, as in Otani
et al. (2016) from CT images or similar. Moreover, boundary
conditions such as the inlet velocity profile should be adapted
to atrial fibrillation (i.e., absence of atrial contraction). More
sophisticated numerical techniques such as Fluid-Structure
interaction (between blood flow and LA wall), contact-based
7http://atriaseg2018.cardiacatlas.org/
(between device and LA wall) or discrete particle models
(for coagulation and thrombus formation Hathcock, 2006)
may provide more realistic simulations, at the expense of
increased computational costs and complexity. In addition,
patient-specific blood flow boundary conditions (e.g., based
on Doppler data), rather than the generic curves used in
this study, would be required for an individualized assessment
of hemodynamics.
The post-processing of CFD simulations has been one of
the most critical steps in the developed modeling pipeline.
For instance, the visualization of blood flow streamlines is
highly dependent on the location of the seeds required to
generate them. An incorrect seed placement can lead to
misinterpretation of CFD simulations and wrong conclusions.
To study LAA blood flow patterns in the LAA it is
convenient to place seeds near the LAA ostium, according
to our experience. Additionally, one needs to be cautious
on using velocity 1D profiles and values evaluated in a
single point in space as an estimation of blood flow pattern
behavior. It is not obvious to select a point in which reliably
comparing velocity profiles for different device configurations,
as shown in Figure 6. This is also critical for the validation
of simulation results with clinical data. We have performed
initial visual comparisons between mitral valve and LAA velocity
profiles from our simulations and from Doppler data of the
studied patients, showing promising similarities. Nevertheless,
a more exhaustive and quantitative validation with more
complete Doppler or 4D-flow MRI data, ideally on several
geometries and with different LAAO devices, is still missing.
In addition, the analysis of a larger number of cases would
allow identifying patients with thromboembolic history and
compare their morphological and hemodynamics parameters
given by VIDAA and biophysical models with patients without
a thrombus.
5. CONCLUSIONS
The VIDAA platform was developed to perform virtual
implantation of LAAO devices on patient-specific geometries
in an interactive way. Its combination with biophysical
models of hemodynamics and complete LAA shape 3D
characterization offers clinicians unprecedented computational
tools to select the optimal device settings prior to the
intervention. Different LAAO device settings can be tested
to minimize the areas prone to thrombus formation after
device implantation, according to in silico indices derived
from CFD simulation results. The LAAO configurations found
after manipulation of device settings in the VIDAA platform
were linked to a reduced risk of thrombus formation outside
the implanted device, according to a qualitatively analysis of
blood flow streamlines and ECAP maps. Future work will
be focused on the evaluation of the VIDAA platform in a
clinical environment, analyzing a larger number of LAA cases
and exploring its use as an alternative to 3D printing for
interventional planning, also in combination with immersive
visualization interfaces.
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